Dimethyl Fumarate Kit
Product Images NDC 33342-579

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Dimethyl Fumarate (NDC 33342-579). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Macleods Pharmaceuticals Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

368 (Dimethyl Fumarate 14 Blister Carton Pack)

Label for Dimethyl Fumarate Delayed-Release Capsules USP, 120 mg strength, oral dosage form. The label specifies swallowing the whole capsule and dispensing in the original package. Manufactured by Macleods Pharmaceuticals Limited with packaging details including storage instructions and a barcode.*

FDA Label Image

322 (Dimethyl Fumarate 60s Bottle 120mg)

Label for Dimethyl Fumarate delayed-release capsules USP, 120 mg strength, oral dosage form. The label indicates 60 capsules per container and shows the manufacturer as Macleods Pharmaceuticals Ltd, with Macleods Pharma USA as the U.S. distributor. Usage instructions and storage conditions are included.*

FDA Label Image

369 (Dimethyl Fumarate 60s Bottle 240mg)

Label of Dimethyl Fumarate delayed-release capsules USP, 240 mg strength. The label indicates 60 capsules per container, with instructions to swallow whole. It includes storage conditions and manufacturer details, listing Macleods Pharma USA, Inc. and Macleods Pharmaceuticals Ltd. The label also has dosage recommendations and multiple barcodes.*

FDA Label Image

Fig (Dimethyl Fumarate Fig 1)

A line graph depicting the percentage of subjects with confirmed progression of disability over time in weeks, comparing placebo and Dimethyl Fumarate 240 mg BID groups. The x-axis shows study duration up to 96 weeks, and the y-axis represents percentage of subjects progressing. Dimethyl Fumarate group shows a lower progression rate (16.4%) versus placebo (27.1%) at week 96.*

FDA Label Image

012 (Dimethyl Fumarate Starter Pack 1)

Label of Dimethyl Fumarate Delayed-Release Capsules USP 30-Day Starter Pack by Macleods Pharmaceuticals Limited. The carton includes a 120 mg starter dose carton with 14 capsules and a 240 mg regular dose carton with 46 capsules. Dosage instructions and storage conditions are also displayed, along with barcode and manufacturing details.*

FDA Label Image

316 (Dimethyl Fumarate Starter Pack 120 mg)

Label for Dimethyl Fumarate Delayed-Release Capsules USP, 120 mg strength. The label indicates dosing instructions for 7 days starting with 120 mg capsules taken twice daily. The labeler is Macleods Pharmaceuticals Limited, showing storage instructions and manufacturing information for Macleods Pharma USA, Inc. This is a prescription oral capsule product.*

FDA Label Image

366 (Dimethyl Fumarate Starter Pack 240 mg)

Label for Dimethyl Fumarate Delayed-Release Capsules USP, 240 mg strength, capsules for oral use. The label includes instructions for use, dosage information, storage conditions, and manufacturer details from Macleods Pharmaceuticals Limited. The label also features a barcode, batch and expiration date fields, and emphasizes the 240 mg dosage on multiple parts of the label.*

FDA Label Image

Str (Dimethyl Fumarate Str)

Chemical structure of Dimethyl Fumarate showing its molecular formula with two carboxyl groups and double bonds represented.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.